Class 2 Medicines Recall: Actavis Group PTC EHF - recall of batches of Irbesartan/Hydrochlorothiazide 300/12.5mg Film-coated Tablets and Irbesartan/Hydrochlorothiazide 150/12.5mg Film-coated Tablets

New feature! Use PharmData's unclaimed EPS scripts tool to identify unclaimed and short-dated EPS prescriptions for your pharmacy, to help streamline your dispensary processes, save money and provide a great service to your patients. Try now for free »

Class 2 Medicines Recall: Actavis Group PTC EHF - recall of batches of Irbesartan/Hydrochlorothiazide 300/12.5mg Film-coated Tablets and Irbesartan/Hydrochlorothiazide 150/12.5mg Film-coated Tablets

2019-01-03 12:30:26 (2 year(s) ago)

Summary

Actavis Group PTC EHF is recalling the below batches from pharmacies as a precautionary measure due to possible contamination with N?nitrosodiethylamine (NDEA).

Read full MHRA article

Respond to this alert